Table 2 Association between HOXA11-AS and clinicopathological characteristics of cancers
Clinicopathological parameters | Studies (n) | Patients (n) | OR (95% CI) | p value | Heterogeneity | ||
|---|---|---|---|---|---|---|---|
I2 (%) | p | Model | |||||
Age (≥ 55 vs. < 55 years) | 4 | 259 | 0.66 (0.40–1.08) | 0.101 | 0 | 0.899 | Fixed |
Gender (male vs. female) | 4 | 259 | 1.05 (0.64–1.72) | 0.845 | 0 | 0.483 | Fixed |
Lymph node metastasis (yes vs. no) | 4 | 384 | 2.06 (1.31–3.25) | 0.002 | 47.1 | 0.129 | Fixed |
Tumor stage (III–IV vs. I–II) | 6 | 480 | 4.22 (2.60–6.85) | < 0.001 | 0 | 0.993 | Fixed |
Tumor differentiation (poor vs. well) | 3 | 292 | 2.49 (1.47–4.20) | 0.001 | 0 | 0.648 | Fixed |